[Randomized double-blind study using mepartricin and a placebo in the therapy of benign prostatic hypertrophy].
Miano
L
L
Manieri
C
C
Paradiso Galatioto
G
G
D000368:Aged; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D008613:Mepartricin / Q000627:therapeutic use*; D008875:Middle Aged; D011090:Polyenes / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D011897:Random Allocation; D014555:Urination Disorders / Q000209:etiology / Q000503:physiopathology; D014563:Urodynamics
D011090:Polyenes; D008613:Mepartricin
Studio randomizzato in doppio cieco con mepartricina e placebo nella terapia dell'iperplasia prostatica benigna.